A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
Xiaoniu Miao, Yingda Xu, Tiong Kit Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuefeng Zou, William James(University of Oxford), Liping Wan, Wenchao Jiang, Yi-Feng Xu, Yao Yan, Alain Townsend(University of Oxford), Weihui Fu, Liandi Chen, Michael L. Knight(University of Oxford), Pramila Rijal(Chinese Academy of Medical Sciences & Peking Union Medical College), Javier Gilbert‐Jaramillo(University of Oxford), Tuling Pang, Suki Man-Yan Lee(University of Hong Kong), Xuedong Song, Xi Huang(Sun Yat-sen University), Yongzhou Tang, Joanne Sun, Xiaolin Liu(The Fifth People’s Hospital of Suzhou), Chao Wang(Anhui Agricultural University), Cheng Chen(Tianjin University), Yi Luo, Andy Tsun(Zhuhai Institute of Advanced Technology), Wei Gao(Fujian Medical University), Fan Wu(China University of Geosciences), Zhijun Yuan
Cited by 35
Related Papers
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Neurological manifestations of dengue infection
|The Lancet|2000|637
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470